When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ABBV - AbbVie opts in to develop fibrotic disease candidates with Morphic
AbbVie Inc.
Morphic Therapeutic (NASDAQ:MORF)announces that collaboration partner and licensee AbbVie (NYSE:ABBV) has exercised its option to develop its ?v?6 integrin inhibitors for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis (IPF) and additional indications.
More news on: Morphic Holding, Inc., AbbVie Inc., Healthcare stocks news,